Priveterra Acquisition Corp. (PMGM) to Combine with AEON Biopharma in $201M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Priveterra (NASDAQ:PMGM) has entered into a definitive agreement to combine with drug developer AEON at an enterprise value of $201.8 million. Irvine, California-based AEON is working on an injection-based migraine treatment to compete with Botox for chronic and frequent sufferers. The combined company is expected to trade on the Nasdaq under the symbol “AEON” once
Read More